Fred Hutchinson Transplant Program at SCCA
Over the years, thousands of patients diagnosed with leukemia, lymphoma, myelodysplasia, multiple myeloma, and other blood cancers or disorders have come to the Fred Hutchinson Transplant Program at SCCA for three good reasons:
Best Transplant Outcomes in the U.S.
The Fred Hutchinson Transplant Program at SCCA was ranked first in outcomes in a four-year study by the National Marrow Donor Program (NMDP) that measured one-year survival rates of patients among 122 transplant centers in the United States.
Most Experienced Transplant Center in the World
The Hutchinson Center has performed more transplants than any other transplant center in the world. And patients who choose to have their transplants at centers that perform a high number of such procedures generally have better outcomes.
Access to the Latest Transplant Research and Techniques
Clinical use of bone marrow and stem cell transplantation was first 
developed at Hutchinson Center and one of Hutchinson Center's founders, Dr. E. Donnall Thomas, won the Nobel Prize in 1990 for this ground-breaking work. Since then Hutchinson Center has pioneered the use of less toxic mini-transplants, cord blood for stem cell transplants, and using transplants to treat many cancers, bone marrow deficiencies, and immune disorders.